Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  DaVita Inc.    DVA

DAVITA INC.

(DVA)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/05/2019 11/06/2019 11/07/2019 11/08/2019 11/11/2019 Date
62.44(c) 70.51(c) 69.19(c) 69.85(c) 69.43(c) Last
1 738 950 6 007 870 2 701 708 2 488 602 1 348 800 Volume
+1.56% +12.92% -1.87% +0.95% -0.60% Change
More quotes
Financials (USD)
Sales 2019 11 424 M
EBIT 2019 1 757 M
Net income 2019 773 M
Debt 2019 7 005 M
Yield 2019 -
Sales 2020 11 568 M
EBIT 2020 1 563 M
Net income 2020 739 M
Debt 2020 7 194 M
Yield 2020 -
P/E ratio 2019 13,0x
P/E ratio 2020 13,0x
EV / Sales2019 1,44x
EV / Sales2020 1,44x
Capitalization 9 441 M
More Financials
Company
DaVita specializes in providing dialysis services. Net sales (including intragroup) break down by activity as follows: - supply of dialysis services (93.5%): hemodialysis and peritoneal dialysis services for patients suffering from chronic renal failure. At the end of 2018, services are insured... 
More about the company
Surperformance© ratings of DaVita Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on DAVITA INC.
11/07DAVITA : Management's Discussion and Analysis of Financial Condition and Results..
AQ
11/05DAVITA INC. : Results of Operations and Financial Condition, Change in Directors..
AQ
11/05DAVITA INC. : 3rd Quarter 2019 Results
PR
11/05DAVITA : Clinical Research Findings Featured at American Society of Nephrology K..
PU
11/04DAVITA INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
10/31DAVITA : New Nephrology Care Alliance generates interest from over 500 physician..
PU
10/29DAVITA : Selects its Next Chief Accounting Officer
PR
10/28DAVITA : Health Solutions Becomes Vively Health™
PU
10/24DAVITA INC. : Schedules 3rd Quarter 2019 Investor Conference Call
PR
10/16DAVITA : Corporate Responsibility Efforts Earn Accolades from Dow Jones
PR
10/14DAVITA : and Colorado Symphony Bring Chopin Chairside to Hundreds of Denver Dial..
PU
10/10DAVITA : 13th Annual Tour DaVita Cycling Event Raises $1.2M for Bridge of Life
PR
08/27DAVITA INC. : Schedules Capital Markets Day for September 10, 2019
PR
08/22DAVITA : Announces Final Results Of Self-Tender Offer
PR
08/21A FORCE FOR CHANGE : DaVita Continues to Prioritize Environmental Sustainability
PU
More news
News in other languages on DAVITA INC.
10/14AKTIE IM FOKUS : FMC unter schwächsten Dax-Werten - Sorgen um US-Dialysegeschäft
07/17US-Apothekenkette CVS will in den Heimdialyse-Markt - FMC-Aktie unter Druck
07/17Aktien Frankfurt: Moderate Verluste - Anlegern fehlt weiter der Mut zum Kauf
07/09Aktien New York: Kaum Bewegung vor Auftritt des Fed-Chefs Powell
07/09AKTIE IM FOKUS : FMC unter Druck - Medienbericht zu Änderungen im US-Dialysemark..
More news
Analyst Recommendations on DAVITA INC.
More recommendations
Sector news : Healthcare Facilities & Services - NEC
11/11UK building sector hit by surge in insurance costs after Grenfell fire
RE
11/06GLOBAL MARKETS LIVE : Xerox, T-Mobile, Sprint, IBM…
11/06CVS HEALTH : Beats Revenue Expectations, Raises Earnings Outlook
DJ
11/05GLOBAL MARKETS LIVE : ArcelorMittal, Adecco, Pandora, Samsung…
11/04Snakes and ladders - SoftBank Vision Fund's climbing, sliding valuations
RE
More sector news : Healthcare Facilities & Services - NEC
Chart DAVITA INC.
Duration : Period :
DaVita Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DAVITA INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 66,92  $
Last Close Price 70,51  $
Spread / Highest target 10,6%
Spread / Average Target -5,09%
Spread / Lowest Target -19,2%
EPS Revisions
Managers
NameTitle
Javier J. Rodriguez Chief Executive Officer & Director
Kent J. Thiry Executive Chairman
Atul Mathur Executive Vice President-Global Operations
Joel Ackerman Chief Financial Officer
Peter Thacher Grauer Lead Independent Non-Executive Director
Sector and Competitors